A globe-spanning scientific team has compiled the most comprehensive list of genetic variants associated with prostate cancer risk -; 451 in all -; through a whole-genome analysis that ranks as the largest and most diverse investigation into prostate cancer genetics yet.
FDA approves first DNA test for risk of opioid use disorder
Dive Brief: The Food and Drug Administration approved the first test that uses DNA to determine whether someone may have a greater risk of developing
December 20, 2023